Status:
COMPLETED
Retrospective Chart Review of Candida Fungemia
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Candida Fungemia
Eligibility:
All Genders
6+ years
Brief Summary
Background: Candida can cause infections. The most common kind of Candida at clinics is C albicans. But other kinds have increased at clinics too. Researchers want to review the records of people who...
Detailed Description
This protocol is a chart review of patients who had Candida species grown from blood cultures drawn at the National Institutes of Health. The study will involve only review of patient records and will...
Eligibility Criteria
Inclusion
- The study will involve only review of patient records and will not require new specimens or participant contact. The patients whose records will be reviewed in this protocol are/were enrolled on a number of different protocols related to their underlying disease(s).
Exclusion
Key Trial Info
Start Date :
January 3 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 18 2020
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03827330
Start Date
January 3 2019
End Date
November 18 2020
Last Update
November 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, Maryland, United States, 20892